Skip to main content

Table 2 Risk groups based on THRI score

From: Validation of the Toronto hepatocellular carcinoma risk index for patients with cirrhosis in China: a retrospective cohort study

THRI score

All patients (n = 520)

HCC (n = 76)

Non-HCC (n = 444)

< 120, n (%)

23 (4.4)

0 (0.0)

23 (5.2)

120–240, n (%)

248 (47.7)

20 (26.3)

228 (51.4)

> 240, n (%)

249 (47.9)

56 (73.7)

193 (43.5)